Effects of nerve growth factor (NGF), fluoxetine, and amitriptyline on gene expression profiles in rat brain

Neuropeptides

Volumn 45, Issue 5, 2011, Pages 317-322

  McGeary, John E ^a,b,c   Gurel, Volkan ^d   Knopik, Valerie S ^a,c   Spaulding, James ^e   McMichael, John ^d  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d Beech Tree Labs   (United States)

^e LOUISIANA TECH UNIVERSITY   (United States)

Author keywords

Antidepressant; Gene expression; Nerve growth factor; Rat

Indexed keywords

AMITRIPTYLINE; CHOLECYSTOKININ A RECEPTOR; DOPAMINE 5 RECEPTOR; FLUOXETINE; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTRANSMITTER RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN RECEPTOR; SODIUM CHLORIDE; SOMATOSTATIN RECEPTOR 3;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

AMITRIPTYLINE; AMYGDALA; ANIMALS; ANTIDEPRESSIVE AGENTS; FLUOXETINE; GENE EXPRESSION PROFILING; HIPPOCAMPUS; MALE; NERVE GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; RECEPTORS, DOPAMINE D5; RECEPTORS, SEROTONIN, 5-HT3; RECEPTORS, SOMATOSTATIN;

RATTUS;

EID: 80052507425     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2011.06.002     Document Type: Article

References (38)

1. Angelucci F., Ricci V., Pomponi M., Conte G., Mathé A.A., Attilio Tonali P., Bria P. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol 2007, 21(8):820-825. (Epub 2007 Aug 22. PubMed PMID: 17715210.).
2. Angelucci F., Ricci V., Spalletta G., Pomponi M., Tonioni F., Caltagirone C., Bria P. Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers. Eur. Neuropsychopharmacol. 2008, 18(12):882-887. (Epub 2008 Sep 6. PubMed PMID: 18774699.).
3. Bhatnagar S., Nowak N., Babich L., Bok L. Deletion of the 5-HT3 receptor differentially affects behavior of males and females in the Porsolt forced swim and defensive withdrawal tests. Behav. Brain Res. 2004, 153(2):527-535.
4. Chisholm D., Sanderson K., Ayuso-Mateos J.L., Saxena S. Reducing the global burden of depression: population-level analysis of intervention cost-effectiveness in 14 world regions. Br. J. Psychiatry 2004, 184:393-403.
5. Covaceuszach S., Capsoni S., Ugolini G., Spirito F., Vignone D., Cattaneo A. Development of a non invasive NGF-based therapy for Alzheimer's disease. Curr. Alzheimer Res. 2009, 6(2):158-170.
6. Drigues N., Poltyrev T., Bejar C., Weinstock M., Youdim M.B. CDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs. J Neural Transm 2003, 110(12):1413-1436.
7. Dunlop B.W., Nemeroff C.B. The role of dopamine in the pathophysiology of depression. Arch. Gen. Psychiatry 2007, 64(3):327-337. (Review).
8. Dwivedi Y. Brain-derived neurotrophic factor: role in depression and suicide. Neuropsychiatr Dis Treat. 2009, 5:433-449. (Epub 2009 Aug 20.).
9. Eisensamer B., Rammes G., Gimpl G., Shapa M., Ferrari U., Hapfelmeier G., Bondy B., Parsons C., Gilling K., Zieglgänsberger W., Holsboer F., Rupprecht R. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry 2003, 8(12):994-1007. (PubMed PMID: 14647397).
10. Engin E., Treit D. Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors. Psychopharmacology (Berl) 2009, 206(2):281-289. (Epub 2009 Jul 17. PubMed PMID: 19609508).
11. Fournier J.C., DeRubeis R.J., Hollon S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., Fawcett J. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 2010, 303(1):47-53.
12. Harrell A.V., Allan A.M. Improvements in hippocampal-dependent learning and decremental attention in 5-HT(3) receptor overexpressing mice. Learn Mem 2003, 10(5):410-419.
13. Inoue H., Iannotti C.A., Welling C.M., Veile R., Donis-Keller H., Permutt M.A. Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM). Genomics 1997, 42(2):331-335.
14. Kato M., Fukuda T., Wakeno M., Fukuda K., Okugawa G., Ikenaga Y., Yamashita M., Takekita Y., Nobuhara K., Azuma J., Kinoshita T. Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. Neuropsychobiology 2006, 53(4):186-195. Epub 2006 Jul 26. PubMed PMID: 16874005.
15. Kenna G.A., McGeary J.E., Swift R.M. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1. Am. J. Health Syst. Pharm. 2004, 61(21):2272-2279. (Review. PubMed PMID: 15552634).
16. Kenna G.A., McGeary J.E., Swift R.M. Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2. Am. J. Health Syst. Pharm. 2004, 61(22):2380-2388. (Review. PubMed PMID: 15581261.).
17. Le Foll B., Gallo A., Le Strat Y., Lu L., Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behav. Pharmacol. 2009, 20(1):1-17. (Review. PubMed PMID: 19179847).
18. Lewin G.R., Rueff A., Mendell L.M. Peripheral and Central Mechanisms of NGF-induced Hyperalgesia. Eur. J. NeuroSci. 1994, 6(12):1903-1912.
19. Liu F., Wan Q., Pristupa Z.B., Yu X.M., Wang Y.T., Niznik H.B. Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature 2000, 403(6767):274-280.
20. Luscher B., Shen Q., Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 2011, 16(4):383-406. (Epub 2010 Nov 16. PubMed PMID: 21079608).
21. Martinowich K., Manji H., Lu B. New insights into BDNF function in depression and anxiety. Nat. Neurosci. 2007, 10(9):1089-1093. (Review).
22. Moncrieff J., Kirsch I. Efficacy of antidepressants in adults. BMJ 2005, 331(7509):155-157. (Review).
23. Overstreet D.H., Fredericks K., Knapp D., Breese G., McMichael J. Nerve growth factor (NGF) has novel antidepressant-like properties in rats. Pharmacol. Biochem. Behav. 2010, 94(4):553-560.
24. Poduslo J.F., Curran G.L. Permeability at the blood-brain and blood-nerve barriers of the eurotrophic factors: NGF, CNTF, NT-3, BDNF. Mol. Brain Res. 1996, 36:280-286.
25. Pommier B., Beslot F., Simon A., Pophillat M., Matsui T., Dauge V., Roques B.P., Noble F. Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system. J. Neurosci. 2002, 22(5):2005-2011. (PubMed PMID: 11880531).
26. Pucilowski O., Overstreet D.H. Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains. Brain Res. Bull. 1993, 32(5):471-475. PubMed PMID: 8221139.
27. Ramamoorthy R., Radhakrishnan M., Borah M. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models. Behav. Pharmacol. 2008, 19(1):29-40. (PubMed PMID: 18195592).
28. Reed A.L., Anderson J.C., Bylund D.B., Petty F., El Refaey H., Happe H.K. Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile rats. Psychopharmacology (Berl) 2009, 205(2):249-259. (Epub 2009 Apr 22. PubMed PMID: 19387616).
29. Reed A.L., Happe H.K., Petty F., Bylund D.B. Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression. Psychopharmacology (Berl) 2008, 197(3):433-441. (Epub 2008 Jan 8. PubMed PMID: 18180907).
30. Saraceno L., Munafó M., Heron J., Craddock N., van den Bree M.B. Genetic and non-genetic influences on the development of co-occurring alcohol problem use and internalizing symptomatology in adolescence. A review. Addiction 2009, 104(7):1100-1121. (Epub 2009 May 11. Review. PubMed PMID: 19438423.).
31. Shi C.G., Wang L.M., Wu Y., Wang P., Gan Z.J., Lin K., Jiang L.X., Xu Z.Q., Fan M. Intranasal administration of nerve growth factor produces antidepressant-like effects in animals. Neurochem. Res. 2010, 35(9):1302-1314. (Epub 2010 Jun 3. PubMed PMID: 20521102).
32. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22(8):3251-3261.
33. Tuszynski M.H., Thal L., Pay M., Salmon DP U.H.S., Bakay R., Patel P., Blesch A., Vahlsing H.L., Ho G., Tong G., Potkin S.G., Fallon J., Hansen L., Mufson E.J., Kordower J.H., Gall C., Conner J. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 2005, 11(5):551-555.
34. Wang J.C., Grucza R., Cruchaga C., Hinrichs A.L., Bertelsen S., Budde J.P., Fox L., Goldstein E., Reyes O., Saccone N., Saccone S., Xuei X., Bucholz K., Kuperman S., Nurnberger J., Rice J.P., Schuckit M., Tischfield J., Hesselbrock V., Porjesz B., Edenberg H.J., Bierut L.J., Goate A.M. Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry 2009, 14(5):501-510. (Epub 2008 Apr 15. PubMed PMID: 18414406).
35. Yamada Y., Reisine T., Law S.F., Ihara Y., Kubota A., Kagimoto S., Seino M., Seino Y., Bell G.I., Seino S. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol. Endocrinol. 1992, 6(12):2136-2142.
36. Yamada M., Yamada M., Higuchi T. Antidepressant-elicited changes in gene expression: remodeling of neuronal circuits as a new hypothesis for drug efficacy. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(6):999-1009.
37. Yevenes G.E., Moraga-Cid G., Avila A., Guzmán L., Figueroa M., Peoples R.W., Aguayo L.G. Molecular requirements for ethanol differential allosteric modulation of glycine receptors based on selective Gbetagamma modulation. J. Biol. Chem. 2010, 285(39):30203-30213. (Epub 2010 Jul 20. PubMed PMID: 20647311; PubMed Central PMCID: PMC2943258.).
38. Yoon S.J., Roh S., Lee H., Lee J.Y., Lee B.H., Kim Y.K., Kim D.J. Possible role of nerve growth factor in the pathogenesis of alcohol dependence. Alcohol. Clin. Exp. Res. 2006, 30(6):1060-1065. (PubMed PMID: 16737466).